Nicholas Hoffman & Company
CLX icon

Nicholas Hoffman & Company’s Clorox CLX Stock Holding History

Nicholas Hoffman & Company’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.18M Buy
14,510
+4,715
+48% +$453K 0.02% 140
2026
Q2 		$935K Buy
+9,795
New +$940K 0.02% 165
2021
Q3 		– Sell
-1,240
Closed -$223K – 268
2021
Q2 		$223K Buy
+1,240
New +$226K 0.04% 244
2021
Q1 		– Sell
-1,017
Closed -$205K – 243
2020
Q4 		$205K Hold
1,017
– – 0.05% 212
2020
Q3 		$214K Buy
1,017
+22
+2% +$4.9K 0.06% 185
2020
Q2 		$218K Buy
+995
New +$199K 0.06% 181
2019
Q2 		– Sell
-1,459
Closed -$234K – 194
2019
Q1 		$234K Buy
+1,459
New +$226K 0.08% 159
2018
Q2 		– Sell
-1,530
Closed -$204K – 173
2018
Q1 		$204K Buy
1,530
+180
+13% +$24.2K 0.08% 167
2017
Q4 		$201K Buy
+1,350
New +$184K 0.08% 164
2016
Q4 		– Sell
-1,670
Closed -$209K – 153
2016
Q3 		$209K Buy
1,670
+54
+3% +$7.07K 0.11% 132
2016
Q2 		$224K Buy
+1,616
New +$210K 0.13% 124

Other funds holding CLX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
VanEck Associates
VanEck Associates New York $165B AUM 72.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Beutel, Goodman & Co
Beutel, Goodman & Co Toronto, Ontario, Canada $12.7B AUM 12.76% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Nicholas Hoffman & Company's CLX Position: Q3 2026 in Review

Nicholas Hoffman & Company increased its Clorox (CLX) stake by 48% in Q3 2026, buying an estimated $453K and bringing the position to 14,510 shares worth $1.18M. The position accounts for 0.02% of the portfolio, ranked #140.

Nicholas Hoffman & Company first reported a position in CLX in Q2 2016 and has held it in 11 quarters since. 832 funds tracked by Wall St. Rank hold CLX as of Q3 2026.

  • Nicholas Hoffman & Company held 14,510 shares of Clorox worth $1.18M as of Q3 2026.
  • Nicholas Hoffman & Company bought 4,715 Clorox shares in Q3 2026, an estimated $453K.
  • Clorox made up 0.02% of Nicholas Hoffman & Company's portfolio in Q3 2026, its #140 holding.
  • Nicholas Hoffman & Company first reported a position in Clorox in Q2 2016 and has held it in 11 quarters since.
  • 832 funds tracked by Wall St. Rank held Clorox as of Q3 2026.

Based on Nicholas Hoffman & Company's 13F filing for Q3 2026, filed 30 Oct 2026.